The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Peptostreptococcus anaerobius promotes colorectal carcinogenesis and modulates tumour immunity
Abstract
Emerging evidence implicates a role of the gut microbiota in colorectal cancer (CRC). Peptostreptococcus anaerobius (P. anaerobius) is an anaerobic bacterium selectively enriched in the faecal and mucosal microbiota from patients with CRC, but its causative role and molecular mechanism in promoting tumorigenesis remain unestablished. We demonstrate that P. anaerobius adheres to the CRC mucosa and accelerates CRC development in Apc Min/+ mice. In vitro assays and transmission electron microscopy revealed that P. anaerobius selectively adheres to CRC cell lines (HT-29 and Caco-2) compared to normal colonic epithelial cells (NCM460). We identified a P. anaerobius surface protein, putative cell wall binding repeat 2 (PCWBR2), which directly interacts with colonic cell lines via α 2/β 1 integrin, a receptor frequently overexpressed in human CRC tumours and cell lines. Interaction between PCWBR2 and integrin α 2/β 1 induces the activation of the PI3K-Akt pathway in CRC cells via phospho-focal adhesion kinase, leading to increased cell proliferation and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) activation. NF-κB in turn triggers a pro-inflammatory response as indicated by increased levels of cytokines, such as interleukin-10 and interferon-γ in the tumours of P. anaerobius-treated Apc Min/+ mice. Analyses of tumour-infiltrating immune cell populations in P. anaerobius-treated Apc Min/+ mice revealed significant expansion of myeloid-derived suppressor cells, tumour-associated macrophages and granulocytic tumour-associated neutrophils, which are associated with chronic inflammation and tumour progression. Blockade of integrin α 2/β 1 by RGDS peptide, small interfering RNA or antibodies all impair P. anaerobius attachment and abolish P. anaerobius-mediated oncogenic response in vitro and in vivo. Collectively, we show that P. anaerobius drives CRC via a PCWBR2-integrin α 2/β 1-PI3K-Akt-NF-κB signalling axis and identify the PCWBR2-integrin α 2/β 1 axis as a potential therapeutic target for CRC.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Some members of this signature, such as F. nucleatum and P. anaerobius, have been shown to promote colorectal carcinogenesis and modulate tumour immunity74,75”
From Gut OncoMicrobiome Signatures (GOMS) as next-generation biomarkers for cancer immunotherapy (2023) · cites this paper as [75]
Citations
Cites
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766
Myeloid-derived-suppressor cells as regulators of the immune system
Gabrilovich, D. I., & Nagaraj, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2506 · Cited by 6,753
Coordinated regulation of myeloid cells by tumours
Gabrilovich, D. I., Ostrand-Rosenberg, S., & Bronte, V. (2012) · Nature Reviews Immunology · doi:10.1038/nri3175 · Cited by 3,544
The gut microbiota, bacterial metabolites and colorectal cancer
Louis, P., Hold, G. L., & Flint, H. J. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3344 · Cited by 2,925
Kostic, A. D., Chun, E., Robertson, L., Glickman, J. N., Gallini, C. A., Michaud, M., Clancy, T. E., Chung, D. C., Lochhead, P., Hold, G. L., et al. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.07.007 · Cited by 2,718
Rubinstein, M. R., Wang, X., Liu, W., Hao, Y., Cai, G., & Han, Y. W. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.07.012 · Cited by 2,476
Wu, S., Rhee, K.-J., Albesiano, E., Rabizadeh, S., Wu, X., Yen, H.-R., Huso, D. L., Brancati, F. L., Wick, E., McAllister, F., et al. (2009) · Nature Medicine · doi:10.1038/nm.2015 · Cited by 1,812
The emerging mechanisms of isoform-specific PI3K signalling
Vanhaesebroeck, B., Guillermet-Guibert, J., Graupera, M., & Bilanges, B. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2882 · Cited by 1,767
Humphries, J. D., Byron, A., & Humphries, M. J. (2006) · Journal of Cell Science · doi:10.1242/jcs.03098 · Cited by 1,711
Potential of fecal microbiota for early-stage detection of colorectal cancer
Zeller, G., Tap, J., Voigt, A. Y., Sunagawa, S., Kultima, J. R., Costea, P. I., Amiot, A., Böhm, J., Brunetti, F., Habermann, N., et al. (2014) · Molecular Systems Biology · doi:10.15252/msb.20145645 · Cited by 1,375
Cited by
Sorted by citations
Items 401–500 of 565
Advances in microbiome in gastrointestinal cancer
Wong, C. C., & Yu, J. (2026) · Holistic Integrative Oncology · doi:10.1007/s44178-026-00241-4 · Cited by 2
Self-citationTumor-associated bacterial effectors: novel frontiers in tumor biology and immunity
Dai, J.-H., Lu, Y.-Q., Feng, S.-Y., Tan, X.-R., Li, L., Zeng, Y.-C., Chen, J., Ma, J., & Liu, N. (2026) · 中国科学通报:英文版 · doi:10.1016/j.scib.2026.04.034 · Cited by 3
Gut microbiota and diet in colorectal cancer: Converging determinants of carcinogenesis
Thakur, B. K., Choudhury, S. R., Turpin, W., & Martín, A. (2026) · Gut Microbes · doi:10.1080/19490976.2026.2664684 · Cited by 4
“48 P. anaerobius further amplifies tumorigenic processes through innate immune signaling.”
Seliger, B., Mantke, R., Naß, N., Dammermann, W., Ocvirk, S., Kah, J., Kalinski, T., & Massa, C. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27104299 · Cited by 3
Synbiotics as a Microbiome-Based Strategy in Colorectal Cancer
Procopciuc, L. M., Hangan, A. C., & Lucaciu, R. L. (2026) · Nutrients · doi:10.3390/nu18101591 · Cited by 2
“Studies have shown that Peptostrep-tococcus anaerobius is enriched in CRC tissues compared to normal mucosa, suggesting a functional role in tumor development rather than a passive association [40,56].”
Eysha, M., Fouani, M., Munir, M., Black, M., Long, A., Elchouemi, M., Singh, S., & Abid, M. B. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1787954 · Cited by 2
The gut microbiome in colorectal cancer: molecular paradigms and translational frontiers
Liu, Y., & Mei, D. (2026) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2026.1864299 · Cited by 2
Fluorescent Peptide Probe for Specific Detection and In Vivo Imaging of Fusobacterium Nucleatum
Wu, H. B., Zhang, B., Lu, Z., Wen, J., Shen, M., Wang, B., Xiong, J., Xu, T., Yang, Z., & Chen, J. (2026) · Analytical Chemistry · doi:10.1021/acs.analchem.6c01904 · Cited by 2
Bacteroides acidifaciens enriched by KRAS mutation promotes colorectal tumorigenesis
Jiao, Y., Cheng, C. H., Gao, X., Li, W., Ji, F., Liang, C., Huang, P., Ko, L. H., Ye, L., Kam, I. C. H., et al. (2026) · Cell Host & Microbe · doi:10.1016/j.chom.2026.08.010 · Cited by 2
Self-citationArtificial intelligence reveals roles of gut microbiota in driving human colorectal cancer evolution
Wan, X. (2021) · WArtificial Intelligence in Cancer · doi:10.35713/aic.v2.i5.69 · Cited by 2
The Microbiota and the Relationship with Colorectal Cancer: Surgical Complications—A Review
Michire, A., Anghel, R. M., Draghia, P. M., Burlacu, M. G., Georgescu, T. F., Georgescu, D. E., Balcangiu‐Stroescu, A.-E., Văcăroiu, I. A., Barbu, M. A., & Gaube, A. (2022) · Gastrointestinal Disorders · doi:10.3390/gidisord4020008 · Cited by 2
Assessment of intestinal status in MPLW515L mutant myeloproliferative neoplasms mice model
Zhu, S., Xu, K., Li, S., Yu, X., Liu, Y., Zhang, Q., Zeng, L., Kailin, X., & Xu, K. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.111091 · Cited by 2
VTwins: inferring causative microbial features from metagenomic data of limited samples
Meng, Q., Zhou, Q., Shi, S., Xiao, J., Ma, Q., Yu, J., Chen, J., & Kang, Y. (2023) · 中国科学通报:英文版 · doi:10.1016/j.scib.2023.10.024 · Cited by 2
Self-citationDas, B. K., Sarma, A., & Goswami, A. K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-16013-4.00018-x · Cited by 2
Metagenomics-guided reengineering of the gut microbiome
Dhotre, D. P., & Karmarkar, B. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-91631-8.00011-1 · Cited by 1
Bakır-Güngör, B., Temiz, M., Canakcimaksutoglu, B., & Yousef, M. (2025) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2025.109813 · Cited by 2
Research Progress on the Correlation between Gut Microbes and Its Metabolites and Colorectal Cancer
李, 贤. (2025) · Medical Diagnosis · doi:10.12677/md.2025.151007 · Cited by 2
Wang, M., Jiang, W., Wei, T., Li, Z., Jiang, Y., Zhou, P., & Chen, B. (2025) · PLoS ONE · doi:10.1371/journal.pone.0321016 · Cited by 2
“Coprobacillus bacteremia–associated bacteria and their potential secondary infections are more likely to cause severe host disease [33,34].”
The microbiome of pseudomyxoma peritonei: a scoping review
Portela, S. D. J., Jain, A., Flood, M. P., Lavelle, A., Guerra, G., Patel, M., Aziz, O., Warrier, S. K., Heriot, A. G., & Mohan, H. M. (2025) · Pleura and Peritoneum · doi:10.1515/pp-2024-0016 · Cited by 3
Huang, H., Ren, J., Jiang, D., Hu, S., Qiao, Y., Tang, B., Xu, P., & Liu, J. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.104967 · Cited by 3
Microbiome in Colorectal Cancer
Huang, P., & Wong, C. C. (2023) · Springer eBooks · doi:10.1007/978-981-19-4492-5_3 · Cited by 3
Self-citationBurgermeister, E., & Ebert, M. P. A. (2023) · Springer eBooks · doi:10.1007/978-981-19-4492-5_4 · Cited by 2
Host-microbiota interactions and oncogenesis: Crosstalk and its implications in etiology
Khan, A. A., Nema, V., & Ashraf, M. T. (2023) · Microbial Pathogenesis · doi:10.1016/j.micpath.2023.106063 · Cited by 2
Almeida, A. S., Tran, T. T. T., Ghosh, T. S., Ribière, C., Foley, C., Azevedo, L. A., Pellanda, P., Frei, W., Hueston, C. M., Kumar, R. S., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.02.24.432654 · Cited by 2
Amanzholkyzy, A., Taskozhina, G., Balmaganbetova, F., Zhexenova, A. N., & Nurgaliyeva, R. (2021) · Medical Journal of the Islamic Republic of Iran · doi:10.47176/mjiri.35.174 · Cited by 1
Mizutani, S., Tamaki, A., Shiba, S., Salim, F., Yamada, M., Takamaru, H., Nakajima, T., Yoshida, N., Ikuta, S., Yachida, T., et al. (2024) · Gut · doi:10.1136/gutjnl-2024-332381 · Cited by 1
Liu, J., Chen, S., Huang, Y., Xu, K., Tan, M., Dai, W., Wang, X., Hou, D., Zhang, S., Chen, J., et al. (2025) · BMC Cancer · doi:10.1186/s12885-025-14142-8 · Cited by 1
“Additionally, MDSCs can increase the risk of colon cancer by modulating interleukin-10 expression [25, 26].”
Impact of Diet, Microbiota, and Postbiotics in Colorectal Cancer (CRC) Management
Madan, A., Chaudhary, P., Saxena, D., Muztaba, M., Patel, M., Sheikh, I. A., Khan, M. T., Begum, T., & Ashique, S. (2025) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-3-031-86065-2_8 · Cited by 1
Climate Change and the Microbial Shift: Unveiling Hidden Risks for Cancer Progression
Gopalakrishnan, V., Saravanan, V., Mahendran, M. I. M. S., Boopathy, V., Vaithianathan, R., & Srinivasan, S. (2025) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-25-0565 · Cited by 2
The role of Gram‐positive cocci in cancer initiation, progression, and its application in therapy
Liang, C., Zhou, Z., Li, P., & Xiao, H. (2025) · International Journal of Cancer · doi:10.1002/ijc.70063 · Cited by 1
“76,77 (D) Invasion and metastasis facilitation: Staphylococcus and Streptococcus in breast cancer cells inhibit the RhoA-ROCK signaling pathway to remodel the cytoskeleton, helping tumor cells resist mechanical stress in blood vessels and promoting metastasis.”
Potential Pathogens Associated with Colorectal Cancer
Nezhadi, J., Kafil, H. S., Mahdavi, F., Sadrkabir, M., Hashemzadeh, S., Moaddab, S. Y., Nouri, R., Mohammadzadeh-Asl, Y., Sattarpour, S., & Rezaee, M. A. (2025) · Current Pharmaceutical Biotechnology · doi:10.2174/0113892010338997241216053634 · Cited by 1
van Dorsten, R. T., & Breiman, R. F. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1625818 · Cited by 1
Periodontal Pathogens and their Involvement in the Oral Carcinogenesis Process
Roi, A., Roi, C. I., Riviș, M., Luca, R. E., Boia, S., & Rusu, L. C. (2025) · Dentistry · doi:10.5772/intechopen.1012256 · Cited by 1
The inhibitory effect of strontium on colorectal cancer and its impact on the gut microbiome
Fan, X., Liao, C., Cai, C., & Shen, M. (2025) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2025.109138 · Cited by 1
Gut Microbiota in Colorectal Cancer Carcinogenesis: The Evolution of Hypotheses
Glazunova, E. V., Kurnosov, A., Molodtsova, P. A., Moskalenko, A. M., Makarov, V. V., & Zlobovskaya, O. A. (2025) · Molecular Biology · doi:10.1134/s0026893325700335 · Cited by 1
Intratumoral microbiota in colorectal cancer: roles, therapeutic potential, and challenges
Zhang, X., Qi, J., Dong, C., Zhang, L., Chen, J., Li, M., Jiang, T., & Song, J. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.11.067 · Cited by 2
“Mechanistically, P.anaero-bius induces MDSC infiltration through the integrin a 2 b 1-NF-j B-CXCL1 axis, and MDSCs secrete immunosuppressive cytokines such as IL-6 and IL-10, directly inhibiting C D4 and CD8 T cell activity, thus promoting CRC tumorigenesis[47,67].”
Sangiorgio, G., Filannino, I. M. P., Migliorisi, G., Bongiorno, D., Musso, N., Privitera, G. F., Santuccio, G., Leotta, D., Calvo, M., & Stefani, S. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1726074 · Cited by 1
Wang, W.-J., Liu, T.-B., Li, Y.-G., Jia, J., Zhao, M.-Q., Huang, Y.-X., Dong, J.-G., Xia, Y., & Liang, J. (2025) · Journal of Pharmacy and Pharmacology · doi:10.1093/jpp/rgaf128 · Cited by 2
Li, C., Jiang, X., Yuan, Y., Chen, X., Pu, S., Lian, K., Li, L., & Wang, Q. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1694842 · Cited by 1
Liu, X., Cai, R., Meng, Y., Xu, Y., Wang, B., Liu, M., Wang, Y., Yu, Y., Lu, C., Wei, Y., et al. (2026) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2026.105220 · Cited by 1
Integrin α2: mode of regulation and functioning in the metastatic cancer cascade
Wang, L., Sun, M., Zhu, H., Deng, H.-L., Zhang, S.-C., & Sun, C.-G. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-07987-5 · Cited by 2
“Integrin α2β1 expressed on the surface of tumor cells itself exerts a direct pro-metastatic effect [85, 90–92].”
Interplay Between Gut Microbiota and Cholesterol Metabolism in Colorectal Cancer
Li, S. W., Au, O. T. H., Lau, E. Y. T., Lu, R. Y., Zaleski, A. L., & Liang, Q. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27062553 · Cited by 1
“For instance, Peptostreptococcus anaerobius has been linked to CRC not only through the activation of pro-oncogenic pathways (e.g., AMPK, NF-κ B, PI3K-Akt) but also specifically via its impact on cholesterol biosynthesis [10].”
Joshi, D., Chauhan, K., Oberoi, H. S., Kumar, D. D., & Taneja, N. K. (2026) · Discover Biotechnology · doi:10.1007/s44340-026-00053-2 · Cited by 1
Zhang, W., Liu, J., Sha, S., Yan, Q., & Ma, Y. (2026) · Microorganisms · doi:10.3390/microorganisms14030707 · Cited by 1
“Recent studies have identified bacteria such as F. nucleatum , toxigenic E. coli , P. anaerobius , and B. fragilis as being closely linked to the pathogenicity of CRC [13,15,18,19,42–47].”
Zhang, M., Du, M., Zhang, W., Huang, R., Li, W., Li, T., Bai, J., Zhang, N., Chen, J., Zhou, J., et al. (2026) · iMetaMed · doi:10.1002/imm3.70033 · Cited by 1
Liu, Y., Liu, J., Niu, D., Hu, L., Kou, F., Jiao, Y., Cao, W., Liu, Q., Fu, X., Hu, C., et al. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-08078-1 · Cited by 1
Reyed, R. M., & Prabhakar, P. K. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-36500-3.00008-8 · Cited by 1
Guo, S., Cao, M., Wu, J. I. A. H. U. I., Ma, W., Liang, D., Xie, H., Xie, Y., Luo, Z., Lai, P., Liu, D., et al. (2026) · Clinical and Translational Medicine · doi:10.1002/ctm2.70667 · Cited by 1
Le, H. T. T., Le, H. X., Huyen, D. T., Tran, T.-A., Quyền, Đ. V., Song, L. H., Tran, T. V., Thas, O., Nhung, P. H., & Tran, T. T. T. (2026) · World Journal of Gastroenterology · doi:10.3748/wjg.v32.i18.118267 · Cited by 1
Microbiomics: Novel Biomarkers of Colorectal Cancer Diagnosis and Prognosis
Yang, L., Meng, W., Yang, T., Zhu, Y., & Wang, Z. (2026) · Diagnostics · doi:10.3390/diagnostics16111582 · Cited by 1
“Peptostreptococcus anaerobius membranous signal domain PCWBR2 crosslinks with colorectal epithelial α 2/ β 1 integrin, propelling an NF-κ B and PI3K-Akt signal cascade to promote uncontrolled cellular multiplication [111].”
Gu, M., Wang, Z., 黄负雪, Li, Y., Liu, Z., Huang, Z., & Chang, P. (2026) · Life Sciences · doi:10.1016/j.lfs.2026.124581 · Cited by 1
Li, Y., Yang, Y., Zhang, X., Huang, Z., Zhang, X., & Wen, J. (2026) · Virulence · doi:10.1080/21505594.2026.2696642 · Cited by 1
“It activates PCWBR2–integrin α2/β1–PI3K – Akt – NF-κB signaling, stimulates TLR2/4–ROS – cholesterol synthesis, and produces the tryptophan metabolite IDA, which inhibits ferroptosis via the AHR – ALDH1A3– FSP1–CoQ10 axis [225,226].”
Marjanovic, M., Maletin, N., Kukic, B. P., Nikolić, I., Petrović, N., Radić, J., Đurić, A., Knezevic, M., Dejanović, B., & Calic, V. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1907957 · Cited by 1
“…including enterotoxigenic Bacteroides fragilis, Fusobacterium nucleatum , pks-positive Escherichia coli , Peptostreptococcus anaerobius , and Streptococcus gallolyticus (Kostic et al., 2013; Kumar et al., 2017; Chung et al., 2018; Long et al., 2019; Pleguezuelos-Manzano et al., 2020).”
Cubillos, S. I., & Tewfik, I. (2022) · Journal of Food Research · doi:10.5539/jfr.v11n2p35 · Cited by 1
“There was also a significant reduction in Peptostreptococcus, Comamonas, and Fusobacterium, which typically have a higher prevalence in CRC patients (Long et al., 2019), although the exact mechanism explaining why is still unclear.”
Background“Aging Gut Microbiota and Colorectal Cancer Pathways Correlations”
Catanzaro, R., Sciuto, M., Fattahi, N., Saidpour, A., & Marotta, F. (2023) · Healthy ageing and longevity · doi:10.1007/978-3-031-14023-5_15 · Cited by 1
Косарева, П. В., Konev, R. A., Godovalov, A. P., Sivakova, L. V., & Самоделкин, Е. И. (2023) · Bulletin of Siberian Medicine · doi:10.20538/1682-0363-2023-3-120-131 · Cited by 1
Zhou, X., Zhao, Y., Zhao, R., Shafi, S., Yang, Y., Liu, G., & Liu, S. (2024) · Journal of Cancer Metastasis and Treatment · doi:10.20517/2394-4722.2023.178 · Cited by 1
Advances in non-invasive screening tests for colorectal cancer and adenoma
Zeng, Y., & Liang, Q. (2024) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/tb-2023-1359 · Cited by 1
Gut Microbial Dysbiosis Induced Exacerbations Influence the Progression of Colorectal Cancer
Sawant, S., Meganathan, P., & Vedagiri, H. (2024) · Biology Bulletin Reviews · doi:10.1134/s2079086424600528 · Cited by 2
“P. gingivalis LPS stimulates CD14, TLR4, TLR2, and the MAPK/ERK and NF-kB pathways (Long et al., 2019).”
InfluentialGut Microbiome in Health and Gastrointestinal Cancer
Lau, H. C.-H. (2023) · Springer eBooks · doi:10.1007/978-981-19-4492-5_2 · Cited by 1
Investigating the Role of Prescription Drugs on the Gut Microbiome
Li, J., & Murdoch, H. (2022) · Journal of Student Research · doi:10.47611/jsrhs.v11i4.3841 · Cited by 1
Elucidating the Gut Microbiome of Colorectal Cancer: 40 Fecal Bacteria as Non-invasive BiomarkersPreprint
Yuan, B., Ma, S., Meng, Q., Du, T., Zhu, Y., Yu, J., Liang, Q., Wang, P., Sun, Z., & Song, C. H. (2020) · Research Square · doi:10.21203/rs.3.rs-113328/v1 · Cited by 1
“Importantly, several genus has been reported the role in CRC, such as Peptostreptococcus [25], Fusobacterium [34, 35], Porphyromonas, Parvimonas, Gemella and Prevotella [41] were extremely upregualted in CRC gut (Fig.”
BackgroundSelf-citationHuang, Y., & Cui, G. (2021) · Research Square · doi:10.21203/rs.3.rs-637295/v1 · Cited by 1
Islam, M. Z., Tran, M. A., Xu, T., Tierney, B. T., Patel, C. J., & Kostic, A. D. (2021) · Research Square · doi:10.21203/rs.3.rs-1195626/v1 · Cited by 1
The Association of Cervical Dysbacteriosis, HPV Oncogene Expression, and Cervical Lesion ProgressionPreprint
Liu, H., Liang, H., di li, Wang, M., & Li, Y. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4000462 · Cited by 1
Shen, X., Li, J., Li, J., Zhang, Y., Li, X., Gao, Q., Cui, Y., Chen, X., Chen, Y., & Fang, J. (2020) · Research Square · doi:10.21203/rs.3.rs-29514/v1 · Cited by 1
Zhao, M., Zhang, X., Wang, F., Hu, X., Xue, Z., Chen, M., & Yue, J. (2023) · Research Square · doi:10.21203/rs.3.rs-2834643/v1 · Cited by 1
Chai, N., Cheng, Y., Xiong, Y., Shi, W., Yao, Y., Yang, L., Sui, H. X., & Zhu, H. (2020) · Research Square · doi:10.21203/rs.3.rs-125313/v1
“Several recent studies have con rmed the link between dysbiosis of the gut microbiome and colorectal cancer [35, 36].”
BackgroundVTwins: Identifying Robust Associations from High-dimensional Data of Limited SamplesPreprint
Meng, Q., Zhou, Q., Ma, Q., Yu, J. Y., Chen, J., & Kang, Y. (2021) · Research Square · doi:10.21203/rs.3.rs-116301/v1
Self-citationZhang, J., Han, W., Xie, C., Gao, M., Wang, X., Hu, X., Zhang, W., Cao, S., Liu, X., Cheng, G., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-338293/v1
Bayesian Statistical Modeling of Metagenomics Sequencing Data
Jiang, S. (2021) · SMU Scholar (Southern Methodist University)
Microbiota-targeted therapeutics in gastrointestinal diseases
Shao, H., & Tan, Z. (2021) · World Chinese Journal of Digestology · doi:10.11569/wcjd.v29.i15.841
The Microbiome Profile In Ulcerative Colitis And PouchitisPreprint
Gao, X., Huang, D., Yang, L., He, A., Li, K., Liu, T., & Liu, G. (2021) · Research Square · doi:10.21203/rs.3.rs-714569/v1
Li, N., Zhou, H., Holden, V. K., Deepak, J., Dhilipkannah, P., Todd, N. W., & Jiang, F. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.04.07.487465
Metagenomics from bench to bedside and from bedside to bench
Jia, H. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91369-0.00006-6 · Cited by 1
Chen, S., Fan, L., Lin, Y., Qi, Y., Xu, C., Ge, Q., Zhang, Y., Wang, Q., Jia, D., Si, J., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1607997/v1
Zhang, J., Han, W., Xie, C., Gao, M., Wang, X., Hu, X., Zhang, W., Cao, S., Liu, X., Cheng, G., et al. (2020) · doi:10.21203/rs.3.rs-22109/v1
“Activation of the PI3K/AKT pathway leads to proliferation of B cells and activation of nuclear factor κlight-chain-enhancer of activated B cells (NF-кB), triggering proin ammatory responses [42].”
BackgroundZhang, J., Han, W., Xie, C., Gao, M., Wang, X., Hu, X., Zhang, W., Cao, S., Liu, X., Cheng, G., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-338293/v2
Tang, S., Mao, S., Chen, Y., Tan, F., Duan, L., Pian, C., & Zeng, X. (2023) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2023.111538
The Interplay Between Immunity and Gut Microbiota in Colon Cancer
Malaspina, L., Petrelli, F., Perotti, B., Arganini, M., & Ambrosio, M. R. (2023) · Interdisciplinary cancer research · doi:10.1007/16833_2023_179
Xu, J., Lu, Y., Huang, Y., Li, L., Ye, S., Xu, X., Jiang, G., Chen, N., & Shen, D. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4626258
Simonenko, N. I., Zlatnik, E. Y., Panova, N. I., Shulgina, O. G., & Maksimov, A. Y. (2023) · South Russian Journal of Cancer · doi:10.37748/2686-9039-2023-4-4-3
Chew, D. C. H., Yim, C., Ali, R. A. R., & El-Omar, E. M. (2024) · Wiley eBooks · doi:10.1002/9781119756422.ch1
Research Progress of Intestinal Flora in Colorectal Cancer
Wei, W., & Zhang, Q. H. (2024) · Journal of Biosciences and Medicines · doi:10.4236/jbm.2024.123010
Comment on “The microbiome and oral cancer: More questions than answers”
Saravanan, M. (2024) · Oral Oncology · doi:10.1016/j.oraloncology.2024.106792
Chang, Y., Huang, Z., Hou, F., Liu, Y., Wang, L., Wang, Z., Sun, Y., Pan, Z., Tan, Y., Ding, L., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22607620
Zhu, J., Xie, H., Yang, Z., Chen, J., Yin, J., Tian, P., Wang, H., Zhao, J., Zhang, H., Lu, W., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23993209
Chang, Y., Huang, Z., Hou, F., Liu, Y., Wang, L., Wang, Z., Sun, Y., Pan, Z., Tan, Y., Ding, L., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22607623
Liu, D., Zhang, R., Chen, S., Sun, B., & Zhang, K. (2022) · Figshare · doi:10.6084/m9.figshare.20367030
Chang, Y., Huang, Z., Hou, F., Liu, Y., Wang, L., Wang, Z., Sun, Y., Pan, Z., Tan, Y., Ding, L., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22607617
Zhu, J., Xie, H., Yang, Z., Chen, J., Yin, J., Tian, P., Wang, H., Zhao, J., Zhang, H., Lu, W., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23993200
Chang, Y., Huang, Z., Hou, F., Liu, Y., Wang, L., Wang, Z., Sun, Y., Pan, Z., Tan, Y., Ding, L., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22607611
Chang, Y., Huang, Z., Hou, F., Liu, Y., Wang, L., Wang, Z., Sun, Y., Pan, Z., Tan, Y., Ding, L., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22607614
Microbiome Manipulation in Coloproctology
Suss, N. R., & Shogan, B. D. (2024) · Springer eBooks · doi:10.1007/978-3-031-59630-8_12
Strategies for Modulating the Gut Microbiome
Bajwa, S., Shahid, A., Ijaz, L., & Ali, M. A. (2024) · Springer eBooks · doi:10.1007/978-981-97-3790-1_18
Microbiome and colorectal cancer drug resistance
Miya, T. V., Belancio, V. P., & Dlamini, Z. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-33475-7.00016-0
Veloo, A. C. M., & Johnson, C. N. (2023) · ClinMicroNow · doi:10.1002/9781683674849.mcm0054
Microorganisms and Other Cancers
Pervaiz, H., & Malik, P. A. (2024) · Springer eBooks · doi:10.1007/978-981-97-6948-3_10
Veloo, A. C. M., & Johnson, C. N. (2023) · ClinMicroNow · doi:10.1002/9781683670438.mcm0054
Human Microbiota and Metabolic Alteration in Cancer Progression and Treatment
Shakartalla, S. B., Elsayed, T. M., Almsailem, F., Almousa, F., Aldaihani, A., & Soliman, S. S. M. (2025) · Springer eBooks · doi:10.1007/978-981-96-1305-2_16
Metadata
- Authors
- Long, X., Wong, C. C., Tong, L., Chu, E. S. H., Ho Szeto, C., Go, M. Y. Y., Coker, O. O., Chan, A. W. H., Chan, F. K. L., Sung, J. J. Y., & Yu, J.
- Affiliations
- Chinese University of Hong Kong (HK)
- Corresponding author
- Yu, Jun
- ORCID
- Venue
- Nature Microbiology
- Published
- 2019-09-09
- Volume
- 4
- Issue
- 12
- Pages
- 2319-2330
- ISSN
- 2058-5276 (ISSN-L)
- OpenAlex
- W2972734154
- Cited by
- 557
- References
- 34
- Citations by year
- 2026: 88 · 2025: 101 · 2024: 87 · 2023: 112 · 2022: 72 · 2021: 64 · 2020: 31
- FWCI
- 13.90
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Nature Microbiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Bacterial Cancer Therapy
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Keywords
- Peptostreptococcus anaerobius, colorectal cancer, colorectal carcinogenesis, gut microbiota, bacterial adhesion, PI3K/Akt signaling, NF-κB, focal adhesion kinase, tumour immunity, myeloid-derived suppressor cells, tumour-associated macrophages, tumor-associated neutrophils, chronic inflammation, ApcMin/+ mice, RGDS peptide, therapeutic target, tumor microenvironment
- MeSH terms
- Animals, Biotin, Cell Survival, Colon, Disease Models, Animal, Humans, Male, Mice, Inbred C57BL, Peptostreptococcus, Colorectal Neoplasms, Signal Transduction, Cytokines, NF-kappa B, Caco-2 Cells, HT29 Cells, Phosphatidylinositol 3-Kinases, Gene Expression Profiling, Integrin alpha2beta1, Cell Proliferation, Mice, Focal Adhesion Protein-Tyrosine Kinases, Gene Knockdown Techniques, Carcinogenesis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review